Nasdaq

Accuray's (ARAY) CyberKnife Improves Prostate Cancer Treatment

Accuray Incorporated ARAY recently announced that new data presented at the 2024 Radiosurgery Society (RSS) Meeting in Chicago supports the use of the CyberKnife System in the treatment of high-risk ...
Nasdaq

New Data from Two Clinical Studies Indicate High-Risk and Recurrent Prostate Cancers Can be Effectively Treated in 5 Days Using the Accuray CyberKnife® System

Data Also Underscores Potential Benefits of CyberKnife System Sub-millimeter Accuracy in Preserving Quality of Life after Treatment for Prostate Cancer "An extensive number of peer-reviewed scientific ...
WTEN

New Data from Two Clinical Studies Indicate High-Risk and Recurrent Prostate Cancers Can be Effectively Treated in 5 Days Using the Accuray CyberKnife® System

Data Also Underscores Potential Benefits of CyberKnife System Sub-millimeter Accuracy in Preserving Quality of Life after Treatment for Prostate Cancer MADISON, Wis., March 26, 2024 /PRNewswire/ -- ...